NDC 69238-1489-01 - Bumetanide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69238-1489
- Requested NDC
- 69238-1489-01
- Package NDCs from labels
- 69238-1489-1, 69238-1489-5, 69238-1489-01
- Manufacturer
- AvPAK
- Effective date
- 2026-03-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Bumetanide - AvPAK | AvPAK | 2026-03-11 | HUMAN PRESCRIPTION DRUG LABEL |
| Bumetanide - A-S Medication Solutions | A-S Medication Solutions | 2026-02-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Bumetanide - NCS HealthCare of KY, LLC dba Vangard Labs | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-10-18 | HUMAN PRESCRIPTION DRUG LABEL |
| Bumetanide Tablets, USP (0.5 mg, 1 mg and 2 mg) Rx Only | Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited | 2023-12-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69238-1489-1 | Bumetanide | 100 in 1 BOTTLE | TABLET | 100 | 9 | |
| 69238-1489-5 | Bumetanide | 500 in 1 BOTTLE | TABLET | 500 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69238-1489 | BUMETANIDE TABLET [AMNEAL PHARMACEUTICALS NY LLC] | 9 | Current NDC, Legacy NDC, 2 package rows | 20231230_9188ab17-8539-48a5-905f-ad35ab5a0b93.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69238-1489-1 | EA - Each | 69238-1489 | c81ed181-9f97-472c-bc60-8fa58b6d3839 | 1 | 2017-12-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bumetanide | BUMETANIDE | Rising Pharma Holdings, Inc | 627c9732-eed1-4435-8d79-2e19ab974fd9 | 2024-06-18 | Boxed warning, Warnings, Adverse reactions | 197419 197417 197418 0Y2S3XUQ5H |
| bumetanide | BUMETANIDE | Bryant Ranch Prepack | a60bfe5f-d0d6-4d15-a3de-32dc68e41af3 | 2024-05-23 | Boxed warning, Warnings, Adverse reactions | 197418 0Y2S3XUQ5H |
| Pure Cornstarch Baby | CORN STARCH | Walgreen Company | d0e9bd13-b568-4f7e-b036-8d23e71ad8bf | 2024-03-25 | Warnings | O8232NY3SJ |
| Bumetanide | BUMETANIDE | Bryant Ranch Prepack | f6f12a41-ae6d-4ce6-9bb1-e32679af665f | 2024-01-26 | Boxed warning, Warnings, Adverse reactions | 197419 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | Amneal Pharmaceuticals NY LLC | 9188ab17-8539-48a5-905f-ad35ab5a0b93 | 2023-12-29 | Boxed warning, Warnings, Adverse reactions | ANDA209724 69238-1490-1 69238-1491-5 69238-1491-1 69238-1489-5 69238-1490-5 69238-1489-1 69238-1491 69238-1490 69238-1489 69238148901 197419 197417 197418 d1961e90-3fcc-4b72-b207-6c9de6d66557 9188ab17-8539-48a5-905f-ad35ab5a0b93 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | A-S Medication Solutions | d85bbced-8a9e-414d-bc88-dd0b68c118df | 2023-12-09 | Boxed warning, Warnings, Adverse reactions | ANDA209724 197418 0Y2S3XUQ5H |
| bumetanide | BUMETANIDE | Zydus Pharmaceuticals (USA) Inc. | 525138cd-832a-41d0-84b0-83921b12bd2a | 2023-12-05 | Boxed warning, Warnings, Adverse reactions | 197419 197417 197418 0Y2S3XUQ5H |
| bumetanide | BUMETANIDE | Zydus Lifesciences Limited | 82eb62ca-c32b-4ff8-9f71-43219b240480 | 2023-12-05 | Boxed warning, Warnings, Adverse reactions | 197419 197417 197418 0Y2S3XUQ5H |
| bumetanide | BUMETANIDE | A-S Medication Solutions | cf29e436-b630-4b03-bb9b-9267ae77dc00 | 2023-11-01 | Boxed warning, Warnings, Adverse reactions | 197418 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | Sandoz Inc | 05cb961d-ac33-4bcf-b04e-411e496c43c1 | 2023-06-30 | Boxed warning, Warnings, Adverse reactions | 197419 197417 197418 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | Civica, Inc. | 308c690f-c2bd-4c32-8728-42ec95425f77 | 2023-04-07 | Boxed warning, Warnings, Adverse reactions | 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | A-S Medication Solutions | 7f9dccf8-37ff-454b-9d55-7f1d631c8483 | 2023-01-25 | Boxed warning, Warnings, Adverse reactions | 197418 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | GLENMARK PHARMACEUTICALS INC., USA | 680563fe-5d3a-49bc-86a5-740bda2acebe | 2023-01-09 | Boxed warning, Warnings, Adverse reactions | 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | A-S Medication Solutions | f6ff0d37-c67d-4b9f-8b62-5deda9783c28 | 2023-01-05 | Boxed warning, Warnings, Adverse reactions | 197417 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | A-S Medication Solutions | 8bed63fb-91ec-4132-ac0a-16c4c6f58d95 | 2023-01-03 | Boxed warning, Warnings, Adverse reactions | 197419 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | Fresenius Kabi USA, LLC | a007f3aa-3977-4be3-a9a2-db3d458bca58 | 2022-09-19 | Boxed warning, Warnings, Adverse reactions | 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | Novadoz Pharmaceuticals LLC | 387edfd4-be85-41cd-8a6d-14e6a022b5a9 | 2022-08-09 | Boxed warning, Warnings, Adverse reactions | 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | Gland Pharma Limited | 4d1ed6b2-c410-4f52-9b8a-aa256c37089e | 2022-06-01 | Boxed warning, Warnings, Adverse reactions | 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | Aphena Pharma Solutions - Tennessee, LLC | 7e47e7b1-d28a-4e12-882f-cf193b7f2697 | 2019-09-30 | Boxed warning, Warnings, Adverse reactions | 197418 0Y2S3XUQ5H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.